Report

India Point of Care Diagnostics Market Report and Forecast 2026-2034

116 pages
India Point of Care Diagnostics Market Report and Forecast 2026-2034

India Point of Care Diagnostics Market Report and Forecast 2026-2034

India Point of Care Diagnostics Market Segment: By Product (Glucose Testing, HbA1c Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Others), By End Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnos... Read more

  • Healthcare
  • Pages : 116
  • Report Delivery Format :  

    pdf ppt xls
  • Author: Pawan Kumar
  • ★ ★ ★ ★ (4.3 out of 5)

Note: The market outlook is subject to frequently evolving global trade dynamics and tariff policies. The report will be updated before delivery to incorporate the latest data, including revised forecasts and a detailed analysis of potential impacts to ensure accuracy & up-to-date insights.

India Point of Care Diagnostics Market Report and Forecast 2026-2034
Study Period
2021-2034
Market (2025)
USD 1.04 Billion
Market (2034)
USD 2.15 Billion
CAGR
8.39%
Major Markets Players
Roche Products (India) Pvt. Ltd., Qiagen India Pvt Ltd., Danaher Corporation, Becton Dickinson Private Limited, BioMérieux and Others
*Note: Partial List Randomly Ordered

Build Your Custom Market Intelligence Report

Customize Your Report

India Point of Care Diagnostics Market Statistics and Insights

Market Size Statistics

  • India Point of Care Diagnostics Market reached USD 1.04 billion 2025
  • Market projected to reach USD 2.15 billion by 2034
  • Market expected to grow at CAGR 8.39% during forecast period

By End Use

  • Hospitals segment holds dominant 41% share diagnostic usage

Competitive Landscape

  • More than 10 companies are actively engaged in producing India Point of Care Diagnostics Market
  • Top 5 companies acquired around 56% of the market share.
  • Roche Products (India) Pvt. Ltd., Qiagen India Pvt Ltd., Danaher Corporation, Becton Dickinson Private Limited, BioMérieux, and others

By Platform

  • Lateral flow assays segment accounts for 33% driven adoption

India Point of Care Diagnostics Market Insights & Analysis

The India Point of Care Diagnostics Market is anticipated to register a 8.39% CAGR during 2026-2034. The market size was valued at USD 1.04 billion in 2025 and is projected to reach USD 2.15 billion by 2034. The market is witnessing strong growth driven by increasing demand for rapid and accurate diagnostic solutions. Government initiatives such as Ayushman Bharat and expansion of primary healthcare infrastructure are supporting the adoption of point-of-care diagnostics across India.

The rising burden of infectious and chronic diseases is further driving demand for quick testing solutions. Additionally, advancements in diagnostic technologies, including portable and user-friendly devices, are enhancing accessibility. The growth of home healthcare and telemedicine services is also contributing to market expansion. Increasing investments in healthcare infrastructure and the presence of global diagnostic companies are further strengthening the market landscape.

India Point of Care Diagnostics Market Dynamics

Key Market Driver: Rising Demand for Rapid and Decentralized Diagnostic Testing

The increasing need for quick and accurate diagnostic results is a major driver for the India point of care diagnostics market. Point-of-care testing enables immediate diagnosis and treatment decisions, improving patient outcomes. The growing prevalence of diseases such as diabetes, cardiovascular conditions, and infectious diseases is driving demand for rapid testing solutions. Studies indicate that point-of-care diagnostics can significantly reduce diagnosis time compared to traditional laboratory testing. Additionally, increasing healthcare awareness and the need for early disease detection are encouraging adoption across hospitals, clinics, and home settings.

Major Industry Challenge: Limited Awareness and Infrastructure in Rural Areas

Despite growing adoption, limited awareness and inadequate healthcare infrastructure in rural areas remain key challenges. Many healthcare facilities lack access to advanced diagnostic devices and trained personnel. Additionally, affordability issues and limited distribution networks can restrict product availability in remote regions. Ensuring consistent quality and reliability of point-of-care tests is also a concern. These challenges can hinder market penetration and require targeted efforts to improve accessibility and awareness. Addressing these gaps is essential for expanding the reach of point-of-care diagnostics across India.

Emerging Trend Shaping Outlook: Growth of Home Based Testing and Digital Health Integration

The increasing adoption of home-based diagnostic solutions is emerging as a key trend in the market. Consumers are increasingly opting for self-testing kits and portable diagnostic devices for convenience and privacy. The integration of digital health technologies, including mobile applications and connected devices, is enhancing patient monitoring and data management. Telemedicine platforms are also supporting remote diagnosis and consultation. Additionally, advancements in microfluidics and molecular diagnostics are enabling more accurate and efficient testing. This trend toward decentralized and digital healthcare is transforming the point-of-care diagnostics landscape in India.


India Point of Care Diagnostics Market Report and Forecast 2026-2034

Need Specific Data, Let’s Customize the Report for You

Request Customization

India Point of Care Diagnostics Market Segment-wise Analysis

By End Use

  • Clinics
  • Hospitals
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratory

The hospitals segment dominates the India Point of Care Diagnostics Market, accounting for approximately 41% of total revenue share. This dominance is driven by the high patient inflow and availability of advanced diagnostic infrastructure in hospitals. Clinics also represent a significant segment, particularly for primary healthcare services. The home segment is witnessing rapid growth due to increasing adoption of self-testing kits and home healthcare services. Assisted living healthcare facilities are gradually adopting point-of-care diagnostics to improve patient care. Laboratories continue to play a role in confirmatory testing, supporting overall market growth across end-use segments.

India Point of Care Diagnostics Market Segment-wise Analysis

By Platform

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

The lateral flow assays segment leads the market with an estimated 33% share, driven by their ease of use, rapid results, and cost-effectiveness. These tests are widely used for detecting infectious diseases and pregnancy testing. Dipsticks are commonly used for routine urine and blood testing. Microfluidics and molecular diagnostics are gaining traction due to their high accuracy and advanced capabilities. Immunoassays are also widely used for various diagnostic applications. Continuous technological advancements are enhancing the performance and reliability of point-of-care diagnostic platforms.

Regional Projection of India Point of Care Diagnostics Market

  • North India
  • South India
  • East India
  • West India

North India leads the market, accounting for approximately 34% share due to high population density and increasing healthcare infrastructure in regions such as Delhi NCR. South India follows with strong adoption driven by advanced healthcare facilities in cities like Bengaluru and Chennai. West India contributes significantly with demand from Mumbai and Pune, supported by higher healthcare investments. East India is gradually emerging as a growth region with improving healthcare access and awareness.

India Point of Care Diagnostics Market: Recent Develpoment (2025)

  • Abbott India Ltd expanded its rapid diagnostic product portfolio targeting infectious disease detection across Indian markets
  • Siemens Healthcare Private Limited introduced advanced point of care testing solutions improving diagnostic accuracy and efficiency
  • Roche Products India strengthened its distribution network enhancing accessibility of diagnostic devices in tier two cities
  • Becton Dickinson Private Limited launched innovative testing platforms supporting decentralized healthcare delivery across India

India Point of Care Diagnostics Market Future Outlook (2034)

The India Point of Care Diagnostics Market is expected to grow at a CAGR of 8.39%, reaching USD 2.15 billion by 2034. Growth will be driven by increasing demand for rapid diagnostics, expansion of healthcare infrastructure, and rising adoption of home-based testing solutions. Technological advancements and AI-driven diagnostics will enhance accuracy and efficiency. The integration of digital health platforms will further support market growth. Additionally, government initiatives and increasing investments in healthcare will drive long-term expansion across urban and rural regions.

Why Choose This Report?

  • Provides a comprehensive overview of the overall market analysis, encompassing key trends, consumer behavior analysis, and risk assessment to support strategic decision-making.
  • Provides accurate, up-to-date insights into market size, segmentation, and emerging opportunities, helping to minimize risk & capitalizing on growth.
  • Gives deep understanding of target audience preferences, investment habits, and communication channels for enhanced product development & marketing effectiveness.
  • Delivers competitive analysis & benchmarking, uncovering the strengths & weaknesses of market competitors to guide strategies.
  • Consolidate comprehensive market intelligence, reducing reasoning & streamlining research efforts.
  • Facilitates customized market segmentation & risk mitigation strategies, fine-tuned to the business objectives.
  • Aids in identifying both market challenges & untapped opportunities within the industry to drive long-term business growth.
  • Provides valuable information based on actual customer data & search trends.

Table of Contents

  1. Introduction
    1. Objective of the study
    2. Product Definition
    3. Market Segmentation
    4. Study Variables
  2. Research Methodology
    1. Secondary Data Points
      1. Companies Interviewed
    2. Primary Data Points
      1. Breakdown of Primary Interviews
  3. Executive Summary
  4. Market Dynamics
    1. Drivers
    2. Challenges
    3. Opportunity Assessment
  5. Recent Trends and Developments
  6. Policy and Regulatory Landscape
  7. India Point of Care Diagnostics Market Overview (2021-2034)
    1. Market Size, By Value (in USD Billions)
    2. Market Share, By Product
      1. Glucose Testing
      2. Hb1Ac Testing
      3. Coagulation Testing
      4. Fertility/Pregnancy
      5. Infectious Disease
      6. Cardiac Markers
      7. Thyroid Stimulating Hormone
      8. Hematology
      9. Primary Care Systems
      10. Others
    3. Market Share, By End Use
      1. Clinics
      2. Hospitals
      3. Home
      4. Assisted Living Healthcare Facilities
      5. Laboratory
    4. Market Share, By Platform
      1. Lateral Flow Assays
      2. Dipsticks
      3. Microfluidics
      4. Molecular Diagnostics
      5. Immunoassays
    5. Market Share, By Prescription Mode
      1. Prescription-based Testing
      2. OTC Testing
    6. Market Share, By Region
      1. North India
      2. South India
      3. East India
      4. West India
    7. Market Share, By Competitors
      1. Competition Characteristics
      2. Revenue Shares
  8. India Glucose Testing Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  9. India Hb1Ac Testing Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  10. India Coagulation Testing Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  11. India Fertility/Pregnancy Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  12. India Infectious Disease Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  13. India Cardiac Markers Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  14. India Thyroid Stimulating Hormone Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  15. India Hematology Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  16. India Primary Care Systems Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  17. India Others Point of Care Diagnostics Market Overview, 2021-2034F
    1. By Value (USD Million)
    2. By End Use- Market Size & Forecast 2021-2034, USD Million
    3. By Platform- Market Size & Forecast 2021-2034, USD Million
    4. By Prescription Mode- Market Size & Forecast 2021-2034, USD Million
  18. Competitive Outlook (Company Profile - Partial List)
    1. Roche Products (India) Pvt. Ltd.
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    2. Qiagen India Pvt Ltd.
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    3. Danaher Corporation
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    4. Becton Dickinson Private Limited
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    5. BioMérieux
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    6. Siemens Healthcare Private Limited
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    7. Abbott India Ltd
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    8. Trividia Health, Inc.
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    9. Spectra Medical India Pvt Ltd
      1. Company Overview
      2. Business Segments
      3. Strategic Alliances/Partnerships
      4. Recent Developments
    10. Others
  19. Contact Us & Disclaimer

Top Key Players & Market Share Outlook

  • Roche Products (India) Pvt. Ltd.
  • Qiagen India Pvt Ltd.
  • Danaher Corporation
  • Becton Dickinson Private Limited
  • BioMérieux
  • Siemens Healthcare Private Limited
  • Abbott India Ltd
  • Trividia Health, Inc.
  • Spectra Medical India Pvt Ltd
  • Others

Frequently Asked Questions

A. The India Point of Care Diagnostics Market is anticipated to witness a rise at a 8.39% during the forecast period, i.e., 2026–34. For further details on this market, request a sample here.

A. The India Point of Care Diagnostics Market size was valued at nearly USD 1.04 billion and is envisioned to reach a value of about USD 2.15 billion For further details on this market, request a sample here.

A. Rising demand for rapid diagnostics, increasing disease prevalence, healthcare expansion, and growing adoption of home testing For further details on this market, request a sample here.

A. Limited rural infrastructure, awareness gaps, affordability issues, and challenges in ensuring diagnostic accuracy For further details on this market, request a sample here.

A. North India leads with strong healthcare infrastructure, high population, and increasing adoption of diagnostic technologies For further details on this market, request a sample here.

A. Q. Who are the leading players in the India Point of Care Diagnostics Market during 2026–34? Roche, Abbott, Siemens Healthcare, Becton Dickinson, Qiagen, and other global diagnostic companies. For further details on this market, request a sample here.

A. AI enhances diagnostics accuracy, enables real time monitoring, improves data analysis, and supports personalized healthcare solutions. For further details on this market, request a sample here.

Few of Our Trusted Clients

  • 3M
  • GE
  • PandG
  • Siemens
  • ONGC
  • Honeywell